{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:52:33Z","timestamp":1790765553848,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/1469-0691.12799","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T15:06:38Z","timestamp":1412175998000},"page":"1119-1125","source":"Crossref","is-referenced-by-count":40,"title":["The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection"],"prefix":"10.1016","volume":"20","author":[{"given":"R.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.J.M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12799_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta\u2010analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2036.2012.05033.x","article-title":"Systematic review: faecal transplantation for the treatment of Clostridium difficile\u2010associated disease","volume":"35","author":"Guo","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12799_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.gtc.2012.08.008","article-title":"Fecal microbiota transplantation: techniques, applications, and issues","volume":"41","author":"Borody","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1111\/1469-0691.12799_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eri.10.14","article-title":"Role of the gut microbiota in defining human health","volume":"8","author":"Fujimura","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/1469-0691.12799_bib6","first-page":"9","article-title":"The normal human anaerobic microflora","volume":"35","author":"Evaldson","year":"1982","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1111\/1469-0691.12799_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/00222615-13-1-45","article-title":"The microbial contribution to human faecal mass","volume":"13","author":"Stephen","year":"1980","journal-title":"J Med Microbiol"},{"key":"10.1111\/1469-0691.12799_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1111\/1469-0691.12799_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/1758-2229.12079","article-title":"Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Environ Microbiol Rep"},{"key":"10.1111\/1469-0691.12799_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/nu5010234","article-title":"Diet\u2013microbiota interactions and their implications for healthy living","volume":"5","author":"Jeffery","year":"2013","journal-title":"Nutrients"},{"key":"10.1111\/1469-0691.12799_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00394-013-0645-0","article-title":"Impact of a very low\u2010energy diet on the fecal microbiota of obese individuals","volume":"53","author":"Simoes","year":"2014","journal-title":"Eur J Nutr"},{"key":"10.1111\/1469-0691.12799_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/fmb.11.142","article-title":"The relationship between gut microbiota and weight gain in humans","volume":"7","author":"Angelakis","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1111\/1469-0691.12799_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.diagmicrobio.2012.11.022","article-title":"The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease","volume":"75","author":"Sha","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12799_bib14","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ajg.2012.93","article-title":"The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?","volume":"107","author":"Damman","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib15","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","article-title":"Anti\u2010inflammatory properties of the short\u2010chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease","volume":"13","author":"Tedelind","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"10.1111\/1469-0691.12799_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JCM.01500-13","article-title":"Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate\u2010producing bacteria in inflammatory bowel disease","volume":"52","author":"Wang","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12799_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"key":"10.1111\/1469-0691.12799_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/apt.12365","article-title":"Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis","volume":"38","author":"Varela","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate\u2010producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"10.1111\/1469-0691.12799_bib21","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti\u2010inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/1469-0691.12799_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","article-title":"Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach","volume":"55","author":"Manichanh","year":"2006","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12799_bib23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1136\/gut.35.1_Suppl.S35","article-title":"Effects of short chain fatty acids on gut morphology and function","volume":"35","author":"Scheppach","year":"1994","journal-title":"Gut"},{"key":"10.1111\/1469-0691.12799_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab"},{"key":"10.1111\/1469-0691.12799_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2005.02639.x","article-title":"Oral butyrate for mildly to moderately active Crohn's disease","volume":"22","author":"Di Sabatino","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","article-title":"Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease","volume":"36","author":"Anderson","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/apt.12699","article-title":"Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children","volume":"39","author":"Sha","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib28","author":"A study to investigate the safety and possible clinical benefit"},{"key":"10.1111\/1469-0691.12799_bib29","author":"Fecal biotherapy for the induction of remission in active ulcerative colitis"},{"key":"10.1111\/1469-0691.12799_bib30","author":"Transplantation of faeces in ulcerative colitis"},{"key":"10.1111\/1469-0691.12799_bib31","author":"Standardized fecal microbiota transplantation for ulcerative colitis"},{"key":"10.1111\/1469-0691.12799_bib32","author":"Standardized fecal microbiota transplantation for Crohn's diseases"},{"key":"10.1111\/1469-0691.12799_bib33","author":"Faecal microbiota transplantation in ulcerative colitis (FOCUS)"},{"key":"10.1111\/1469-0691.12799_bib34","author":"Fecal microbiota transplantation in children with ulcerative colitis"},{"key":"10.1111\/1469-0691.12799_bib35","author":"Manipulating the microbiome in IBD by antibiotics and FMT"},{"key":"10.1111\/1469-0691.12799_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","article-title":"A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome","volume":"55","author":"Codling","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1111\/1469-0691.12799_bib37","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2036.2012.05007.x","article-title":"Functional dysbiosis within the gut microbiota of patients with constipated\u2010irritable bowel syndrome","volume":"35","author":"Chassard","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12799_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/gut.2007.144543","article-title":"Luminal hydrogen sulfide plays a pronociceptive role in mouse colon","volume":"58","author":"Matsunami","year":"2009","journal-title":"Gut"},{"issue":"Pt 6","key":"10.1111\/1469-0691.12799_bib39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1099\/jmm.0.028126-0","article-title":"Microbial community and metabolomic comparison of irritable bowel syndrome faeces","volume":"60","author":"Ponnusamy","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1111\/1469-0691.12799_bib40","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22","author":"Tana","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/1469-0691.12799_bib41","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3748\/wjg.15.2887","article-title":"Lower bifidobacteria counts in both duodenal mucosa\u2010associated and fecal microbiota in irritable bowel syndrome patients","volume":"15","author":"Kerckhoffs","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib42","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta\u2010analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bpg.2013.03.003","article-title":"Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?","volume":"27","author":"Vrieze","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/1469-0691.12799_bib44","author":"Fecal microbiota transplantation in patients with irritable bowel syndrome"},{"key":"10.1111\/1469-0691.12799_bib45","doi-asserted-by":"crossref","first-page":"e94433","DOI":"10.1371\/journal.pone.0094433","article-title":"Association between obesity and selected morbidities: a study of BRICS countries","volume":"9","author":"Shukla","year":"2014","journal-title":"PLoS One"},{"key":"10.1111\/1469-0691.12799_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet\u2010induced obesity in germ\u2010free mice","volume":"104","author":"Backhed","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/1469-0691.12799_bib47","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1096\/fj.10-164921","article-title":"Germ\u2010free C57BL\/6J mice are resistant to high\u2010fat\u2010diet\u2010induced insulin resistance and have altered cholesterol metabolism","volume":"24","author":"Rabot","year":"2010","journal-title":"FASEB J"},{"key":"10.1111\/1469-0691.12799_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1463-1326.2011.01483.x","article-title":"The therapeutic potential of manipulating gut microbiota in obesity and type\u00a02 diabetes mellitus","volume":"14","author":"Kootte","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/1469-0691.12799_bib49","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/1469-0691.12799_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet\u2010induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1111\/1469-0691.12799_bib51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/j.gastro.2009.08.042","article-title":"High\u2010fat diet determines the composition of the murine gut microbiome independently of obesity","volume":"137","author":"Hildebrandt","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12799_bib52","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"10.1111\/1469-0691.12799_bib53","first-page":"2816","article-title":"Resting energy expenditure and gut microbiota in obese and normal weight subjects","volume":"17","author":"Kocelak","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1111\/1469-0691.12799_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity"},{"key":"10.1111\/1469-0691.12799_bib55","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ijo.2013.20","article-title":"Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli","volume":"37","author":"Million","year":"2013","journal-title":"Int J Obes"},{"key":"10.1111\/1469-0691.12799_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11908-012-0301-5","article-title":"The role of the manipulation of the gut microbiota in obesity","volume":"15","author":"Million","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/1469-0691.12799_bib57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ajcn\/53.3.681","article-title":"Interaction between colonic acetate and propionate in humans","volume":"53","author":"Wolever","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/1469-0691.12799_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1079\/BJN19870045","article-title":"Origin and utilization of volatile fatty acids and lactate in the rabbit: influence of the faecal excretion pattern","volume":"57","author":"Vernay","year":"1987","journal-title":"Br J Nutr"},{"key":"10.1111\/1469-0691.12799_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2275(20)39028-3","article-title":"Propionic acid as a precursor in the biosynthesis of animal fatty acids","volume":"2","author":"Masoro","year":"1961","journal-title":"J Lipid Res"},{"key":"10.1111\/1469-0691.12799_bib60","doi-asserted-by":"crossref","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type\u00a02 diabetes differs from non\u2010diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"key":"10.1111\/1469-0691.12799_bib61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12799_bib62","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1111\/1469-0691.12799_bib63","author":"Fecal microbiota transplantation for the treatment of metabolic syndrome"},{"key":"10.1111\/1469-0691.12799_bib64","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","article-title":"Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity","volume":"60","author":"Vrieze","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/1469-0691.12799_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross\u2010national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12799_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QCO.0b013e3283553441","article-title":"Methicillin\u2010resistant Staphylococcus aureus and vancomycin\u2010resistant enterococci, and other Gram\u2010positives in healthcare","volume":"25","author":"Calfee","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/1469-0691.12799_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/dki180","article-title":"Risk factors associated with extended\u2010spectrum beta\u2010lactamase\u2010producing organisms at a tertiary care hospital","volume":"56","author":"Graffunder","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12799_bib68","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/521260","article-title":"Screening for extended\u2010spectrum beta\u2010lactamase\u2010producing Enterobacteriaceae among high\u2010risk patients and rates of subsequent bacteremia","volume":"45","author":"Reddy","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12799_bib69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1111\/1469-0691.12799_bib70","doi-asserted-by":"crossref","first-page":"e26988","DOI":"10.1371\/journal.pone.0026988","article-title":"Altering host resistance to infections through microbial transplantation","volume":"6","author":"Willing","year":"2011","journal-title":"PLoS One"},{"key":"10.1111\/1469-0691.12799_bib71","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1128\/IAI.71.6.3443-3453.2003","article-title":"Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium","volume":"71","author":"Vallance","year":"2003","journal-title":"Infect Immun"},{"key":"10.1111\/1469-0691.12799_bib72","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/IAI.01197-12","article-title":"Intestinal microbiota containing Barnesiella species cures vancomycin\u2010resistant Enterococcus faecium colonization","volume":"81","author":"Ubeda","year":"2013","journal-title":"Infect Immun"},{"key":"10.1111\/1469-0691.12799_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/1469-0691.12683","article-title":"Donor faeces infusion for eradication of extended\u2010spectrum \u03b2\u2010lactamase\u2010producing Escherichia coli in a patient with end\u2010stage renal disease","author":"Singh","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12799_bib74","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri3535","article-title":"Microbiota\u2010mediated colonization resistance against intestinal pathogens","volume":"13","author":"Buffie","year":"2013","journal-title":"Nat Rev Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T09:28:14Z","timestamp":1717406894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14653039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1198743X14653039"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12799","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}